GP Superdrol 20

Manufacturer: Geneza Pharmaceuticals

Pharmaceutical name: Methyldrostanolone

Pack: 1 pack (50 tabs (20 mg/tab))

GP Superdrol 20 is a potent oral anabolic steroid derived from dihydrotestosterone, sharing a structure with Drostanolone. The key distinction is the presence of a methyl radical in the 17-alpha position, enhancing its bioactivity when administered orally. These two substances are quite similar. Both Drostanolone and Methyldrostanolone do not undergo aromatization, lack estrogenic effects, and exhibit the same anabolic to androgenic ratio. Research has demonstrated that Methyldrostanolone possesses four times more anabolic potency than Methyltestosterone while retaining only 20% androgenic activity. This steroid has gained popularity among athletes for its ability to increase lean muscle mass without causing water retention or fat gain.

 

For men, the effective dosage of GP Superdrol 20 for improving physique ranges from 10-20 mg daily, limited to a period of 6-8 weeks. This dosage can lead to noticeable muscle gain along with fat loss and enhanced vascularity. However, one should not expect to gain 30 pounds; most individuals will add approximately 10 pounds. Higher dosages can impose additional strain on the liver. Sometimes, a dosage of 20 mg is combined with non-toxic substances such as Testosterone, Deca 300, or Boldenone, which promotes further muscle development. It is also frequently stacked with Primobolan or Trenbolone for cutting phases.

 

For women, the effective dose of GP Superdrol 20 for enhancing physical form is approximately 2.5 mg per day, not exceeding 4-6 weeks, to minimize the risk of virilization.

 

Methyldrostanolone is devoid of aromatization and does not exhibit estrogenic activity, making anti-estrogens unnecessary; sensitive users typically do not experience gynecomastia symptoms. Generally, estrogen is associated with water retention, but this steroid promotes quality weight gain without excess fluid. This characteristic is beneficial for "cutting" phases where water retention and fat are primary concerns.

 

GP Superdrol 20 is categorized as an anabolic steroid, but the potential for androgenic side effects remains. These may include oily skin, acne, and increased body and facial hair. Higher dosages are likely to exacerbate these effects.

 

Women must also be cautious of potential virilization effects from AAS use. This may manifest as a deepened voice, irregular menstrual cycles, changes in skin texture, facial hair growth, and clitoral enlargement. GP Superdrol 20 does not interact with 5-alpha reductase, and its androgenic properties are unaffected by the concurrent use of Finasteride or Dutasteride. GP Superdrol 20 has a low androgenic activity threshold, making the likelihood of androgenic side effects significantly higher compared to Testosterone, Fluoxymesterone, or Methandrostenolone.